BioEcho Life Sciences, a specialized solution provider for the extraction and analysis of nucleic acids, is participating in analytica 2024, the international trade fair for laboratory technology and pioneering biotechnology. The event will take place in Munich from 9 – 12 April 2024.

At analytica 2024, BioEcho will proudly unveil its latest product, the EchoLUTION Tissue RNA Kit. Designed to streamline and optimize total RNA extraction from mammalian tissues (including challenging tissues such as muscle), the EchoLUTION Tissue RNA Kit offers numerous advantages over traditional methods, providing researchers with unprecedented flexibility and versatility. This product significantly reduces processing time and increases efficiency in the laboratory. It delivers highly pure RNA free of contaminants and inhibitors, ensuring reliable and reproducible results in downstream applications such as RT-qPCR and RNA-seq. The EchoLUTION Tissue RNA Kit demonstrates the BioEcho commitment to sustainability and eco-conscious practices with up to 50 % less plastic consumption compared to other extraction methods and eliminating the need for hazardous reagents such as phenol-chloroform.

"We are thrilled to introduce the EchoLUTION Tissue RNA Kit at analytica 2024," said Christiane Schlottbom, Director Marketing at BioEcho Life Sciences. "This innovative solution represents a significant advancement in RNA extraction technology, offering researchers unparalleled speed, efficiency, and reliability in their experiments. We believe that the EchoLUTION Tissue RNA Kit will greatly enhance the workflow of scientists working in diverse fields of molecular biology."

Attendees of analytica 2024 are encouraged to visit the BioEcho booth (Hall 3, Booth 404) to learn more about the EchoLUTION Tissue RNA Kit and explore other cutting-edge products and solutions offered by the company.

For more information about BioEcho Life Sciences and its products, visit our website.

About BioEcho Life Sciences GmbH

BioEcho Life Sciences is a specialized solution provider for the extraction and analysis of nucleic acids. We create disruptive technologies, products, and workflows that make downstream processing of nucleic acids easier and faster, significantly increase throughput, and deliver reliable results. Our EchoLUTION technology enables the fastest DNA and RNA extraction on the market - in just one single step - and drastically reduces the associated plastic consumption.

BioEcho, headquartered in Cologne, Germany, was founded in 2016 by leading industry experts. The headquarters is certified according to ISO 9001 and ISO 13485.

BioEcho. The Nucleic Acid Experts.

www.bioecho.com